Immunotherapy;Keytruda;TNBC;triple negative breast cancer;phase 1 clinical trial

Novel Immunotherapy Approach at Roswell Park Shows Promise in Metastatic Triple-Negative Breast Cancer

[ad_1] Phase 1 clinical trial documents boost in cancer-killing cytotoxic T cells Systemic therapy shows effects even on distant metastatic…